Compare BZH & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BZH | BVS |
|---|---|---|
| Founded | 1985 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 694.0M | 716.8M |
| IPO Year | 1995 | 2016 |
| Metric | BZH | BVS |
|---|---|---|
| Price | $27.02 | $8.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $32.00 | $14.00 |
| AVG Volume (30 Days) | 446.7K | ★ 678.8K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.04 |
| Revenue | ★ $2,087,739,000.00 | $568,087,000.00 |
| Revenue This Year | $4.36 | $7.52 |
| Revenue Next Year | $10.79 | $7.06 |
| P/E Ratio | ★ N/A | $218.13 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.83 | $5.81 |
| 52 Week High | $28.33 | $11.25 |
| Indicator | BZH | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 61.97 | 43.86 |
| Support Level | $20.41 | $8.43 |
| Resistance Level | $27.81 | $9.27 |
| Average True Range (ATR) | 1.04 | 0.38 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 63.64 | 57.14 |
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.